Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage

Abstract

The four members of the ErbB family of receptor tyrosine kinases (RTKs) mediate a variety of cellular responses to epidermal growth factor (EGF)-like growth factors, and serve as a model for the generation of both diversity and specificity in RTK signaling. Previous studies indicate that receptor–receptor interactions figure prominently in signaling through ErbB receptors. In addition to a role in receptor kinase activation, ligand-induced ErbB receptor homo- and heterodimerization is thought to account for the diversity of biological responses stimulated by EGF-like growth factors. Since each receptor has the potential to couple to different complements of signaling pathways, EGF-like ligands specify cellular response by dictating which pairs of receptors become activated. More recently evidence has been uncovered for ligand discrimination by individual ErbB receptor dimers; receptors appear to realize which ligand is binding and differentially respond through autophosphorylation site usage. These observations indicate that ligand stimulation of RTKs is not generic, and point to another layer in the ErbB signal diversification mechanism. The mechanistic implications of ligand discrimination are discussed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Alroy I and Yarden Y. . 1997 FEBS Lett. 410: 83–86.

  • Burden S and Yarden Y. . 1997 Neuron 18: 847–855.

  • Burke CL, Lemmon MA, Coren BA, Engelman DM and Stern DF. . 1997 Oncogene 14: 687–696.

  • Burke CL and Stern DF. . 1998 Mol. Cell. Biol. 18: 5371–5379.

  • Carraway KL III and Cantley LC. . 1994 Cell 78: 5–8.

  • Carraway KL III, Rossi EA, Komatsu M, Price-Schiavi SA, Huang D, Guy PM, Carvajal ME, Fregien N, Carraway CA and Carraway KL. . 1999 J. Biol. Chem. 274: 5263–5266.

  • Chan FK, Chun HJ, Zheng L, Siegel RM, Bui KL and Lenardo MJ. . 2000 Science 288: 2351–2354.

  • Crovello CS, Lai C, Cantley LC and Carraway KL III. . 1998 J. Biol. Chem. 273: 26954–26961.

  • Day RM, Cioce V, Breckenridge D, Castagnino P and Bottaro DP. . 1999 Oncogene 18: 3399–3406.

  • Dodge K and Scott JD. . 2000 FEBS Lett. 476: 58–61.

  • Follenzi A, Bakovic S, Gual P, Stella MC, Longati P and Comoglio PM. . 2000 Oncogene 19: 3041–3049.

  • Fujioka Y, Matozaki T, Noguchi T, Iwamatsu A, Yamao T, Takahashi N, Tsuda M, Takada T and Kasuga M. . 1996 Mol. Cell. Biol. 16: 6887–6899.

  • Gamett DC, Pearson G, Cerione RA and Friedberg I. . 1997 J. Biol. Chem. 272: 12052–12056.

  • Ghiglione C, Carraway KL III, Amundadottir LT, Boswell RE, Perrimon N and Duffy JB. . 1999 Cell 96: 847–856.

  • Graus-Porta D, Beerli RR, Daly JM and Hynes NE. . 1997 EMBO J. 16: 1647–1655.

  • Guy PM, Platko JV, Cantley LC, Cerione RA and Carraway KL III. . 1994 Proc. Natl. Acad. Sci. USA 91: 8132–8136.

  • Heldin CH. . 1995 Cell 80: 213–223.

  • Huang GC, Ouyang X and Epstein RJ. . 1998 Biochem. J. 331: 113–119.

  • Hubbard SR, Mohammadi M and Schlessinger J. . 1998 J. Biol. Chem. 273: 11987–11990.

  • Jiang G and Hunter T. . 1999 Curr. Biol. 9: R568–R571.

  • Karunagaran D, Tzahar E, Beerli RR, Chen X, Graus-Porta D, Ratzkin BJ, Seger R, Hynes NE and Yarden Y. . 1996 EMBO J. 15: 254–264.

  • Kharitonenkov A, Chen Z, Sures I, Wang H, Schilling J and Ullrich A. . 1997 Nature 386: 181–186.

  • LaRochelle WJ, Sakaguchi K, Atabey N, Cheon HG, Takagi Y, Kinaia T, Day RM, Miki T, Burgess WH and Bottaro DP. . 1999 Biochemistry 38: 1765–1771.

  • Lesa GM and Sternberg PW. . 1997 Mol. Biol. Cell. 8: 779–793.

  • Livnah O, Stura EA, Middleton SA, Johnson DL, Jolliffe LK and Wilson IA. . 1999 Science 283: 987–990.

  • Lonardo F, Di Marco E, King CR, Pierce JH, Segatto O, Aaronson SA and Di Fiore PP. . 1990 New Biol. 2: 992–1003.

  • Margolis B. . 1992 Cell Growth Differ. 3: 73–80.

  • Murali R, Brennan PJ, Kieber-Emmons T and Greene MI. . 1996 Proc. Natl. Acad. Sci. USA 93: 6252–6257.

  • Ochi F, Matozaki T, Noguchi T, Fujioka Y, Yamao T, Takada T, Tsuda M, Takeda H, Fukunaga K, Okabayashi Y and Kasuga M. . 1997 Biochem. Biophys. Res. Commun. 239: 483–487.

  • Olayioye MA, Graus-Porta D, Beerli RR, Rohrer J, Gay B and Hynes NE. . 1998 Mol. Cell. Biol. 18: 5042–5051.

  • Olayioye MA, Neve RM, Lane HA and Hynes NE. . 2000 EMBO J. 19: 3159–3167.

  • Otsuka T, Jakubczak J, Vieira W, Bottaro DP, Breckenridge D, Larochelle WJ and Merlino G. . 2000 Mol. Cell. Biol. 20: 2055–2065.

  • Papoff G, Hausler P, Eramo A, Pagano MG, Di Leve G, Signore A and Ruberti G. . 1999 J. Biol. Chem. 274: 38241–38250.

  • Pawson T and Scott JD. . 1997 Science 278: 2075–2080.

  • Pinkas-Kramarski R, Shelly M, Glathe S, Ratzkin BJ and Yarden Y. . 1996 J. Biol. Chem. 271: 19029–19032.

  • Plowman GD, Green JM, Culouscou JM, Carlton GW, Rothwell VM and Buckley S. . 1993 Nature 366: 473–475.

  • Rameh LE and Cantley LC. . 1999 J. Biol. Chem. 274: 8347–8350.

  • Remy I, Wilson IA and Michnick SW. . 1999 Science 283: 990–993.

  • Riese DJ II and Stern DF. . 1998 Bioessays 20: 41–48.

  • Shak S. . 1999 Semin. Oncol. 26: 71–77.

  • Siegel RM, Frederiksen JK, Zacharias DA, Chan FK, Johnson M, Lynch D, Tsien RY and Lenardo MJ. . 2000 Science 288: 2354–2357.

  • Stein E, Lane AA, Cerretti DP, Schoecklmann HO, Schroff AD, Van Etten RL and Daniel TO. . 1998 Genes Dev. 12: 667–678.

  • Sweeney C, Lai C, Riese DJ II, Diamonti AJ, Cantley LC and Carraway KL III. . 2000 J. Biol. Chem. 275: 19803–19807.

  • Syed RS, Reid SW, Li C, Cheetham JC, Aoki KH, Liu B, Zhan H, Osslund TD, Chirino AJ, Zhang J, Finer-Moore J, Elliott S, Sitney K, Katz BA, Matthews DJ, Wendoloski JJ, Egrie J and Stroud RM. . 1998 Nature 395: 511–516.

  • Timms JF, Carlberg K, Gu H, Chen H, Kamatkar S, Nadler MJ, Rohrschneider LR and Neel BG. . 1998 Mol. Cell. Biol. 18: 3838–3850.

  • Tzahar E, Waterman H, Chen X, Levkowitz G, Karunagaran D, Lavi S, Ratzkin BJ and Yarden Y. . 1996 Mol. Cell. Biol. 16: 5276–5287.

  • Tzahar E, Pinkas-Kramarski R, Moyer JD, Klapper LN, Alroy I, Levkowitz G, Shelly M, Henis S, Eisenstein M, Ratzkin BJ, Sela M, Andrews GC and Yarden Y. . 1997 EMBO J. 16: 4938–4950.

  • van der Geer P and Pawson T. . 1995 Trends Biochem. Sci. 20: 277–280.

  • Weiss A and Schlessinger J. . 1998 Cell 94: 277–280.

  • Wilson IA and Jolliffe LK. . 1999 Curr. Opin. Struct. Biol. 9: 696–704.

Download references

Acknowledgements

This work was supported by grant CA71702 from the National Institutes of Health to KL Carraway. C Sweeney is supported by a grant from the Massachusetts Department of Public Health Breast Cancer Research Program.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sweeney, C., Carraway, K. Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage. Oncogene 19, 5568–5573 (2000). https://doi.org/10.1038/sj.onc.1203913

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203913

Keywords

This article is cited by

Search

Quick links